LPO and metastatic colorectal cancer: Because LPO did not show any cytotoxicity to the surrounding normal cells and tissues of colorectal organs, this important enzyme should be considered in further in vitro and in vivo trials as the possibility of using it as a new systemic immunotherapy for metastatic colorectal cancer treatment.